Skip to main content
. 2019 Feb 4;63(3):407–421. doi: 10.1007/s12020-018-01835-3

Table 1.

Post ACTH stimulation test of Δ5-17-hydroxypregnenolone in patients with 3βHSD2D confirmed by HSD3B2 mutation analysis [13]

Neonates with ambiguous genitalia ≥378 nmol/L
Tanner stage I children with ambiguous genitalia ≥165 nmol/L
Children with premature pubarche ≥294 nmol/L
Adults ≥289 nmol/L